Pillar Biosciences, Inc., the leader in Decision Medicine™, today announced they have received nationwide Medicare coverage ...

The firm's next-generation sequencing-based test detects single nucleotide variants, insertions, and deletions in 22 genes.

Sri Lanka’s largest private sector retail bank, HNB PLC, announced the successful completion of an ambitious and ...

In the National Stock Exchange, shares of GR Infraprojects is currently trading at ₹1057 on April 4, 2025, which is a 1.91% ...

The Ontario Institute for Cancer Research (OICR) has announced its support for five Ontario research teams working to develop the next generation of medicines that kill tumours more effectively, cause ...

The firm believes VVD-159642 has the potential to treat a broad patient population, including those with RAS- and HER2-overexpressed tumors.